Mapping pH at the surface of individual cell

绘制单个细胞表面的 pH 值

基本信息

  • 批准号:
    8547803
  • 负责人:
  • 金额:
    $ 22.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-19 至 2015-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The acidity is associated with development of various pathological states such as solid tumors, ischemic stroke, neurotrauma, epileptic seizure, inflammation, infection, wounds, cystic fibrosis and others. Normal cell could be distinguished from highly glycolytic cell (for example, metastatic cancer cell) by transmembrane pH gradient and value of pH at surface of plasma membrane. We propose to develop novel tool to map pH at the extracellular and intracellular surfaces of individual cell in highly heterogeneous environment of cells in vivo. The tool would allow opening an opportunity to contribute in understanding of diseases progression and development of approaches of pH-based image-guided intervention. We will employ optical spectroscopic and imaging approaches, which allow achieving cellular resolution. Our strategy is based on use of peptides of pHLIP (pH Low Insertion Peptide) family. pHLIPs are water-soluble membrane peptides, which insert and fold in lipid bilayer of membrane only at slightly acidic conditions. Since the equilibrium is strongly shifted toward membrane inserted form at low pH, pHLIP injected into blood, circulates in body and accumulates in acidic tissue of tumors, site of inflammatory arthritis and ischemic regions. At 24 h after i.p. or i.v. administration of pHLIP, it is washed out completely from the blood and stays in plasma membrane of cells with low extracellular pH. pHLIP labeled with optical, PET or SPECT probes is considered to be first acidity markers, which are currently under development for clinical uses. We plan to conjugate pHLIP peptides of different pKa of insertion into membrane ranging from 4.5 to 6.5 with pH-sensitive fluorophore, SNARF-1. The main goal of using pHLIPs is to deliver and tether optical probe to the outer or inner leaflet of bilayer of plasma membrane. The SNARF-1 was selected, since it demonstrates shift of the emission spectra in response to pH, which solves the problem of calibration for the probe concentration. The probe will be attached to the N- or C- terminus of pHLIPs. In first case, SNARF-1 will stay in the extracellular space being tethered to the cell surface. On the other hand, when SNARF-1 would be conjugated with the peptide inserting end (C-terminus), pHLIP would "flip" SNARF-1 across the bilayer and expose it to the intracellular space, while keeping it close to the inner leaflet of membrane. Thus, we propose to measure pH from the outer and inner leaflets of plasma membrane and identify transmembrane pH gradient. Experiments in solution, 2D and 3D cell culture, as well as on mouse cancer models will be performed. Our goals are: - to map pH at the surface of cancer cells in a process of cell division and migration in 3D culture; - to map pH on the surface of individual cells in tumors implanted into mice; - to monitor kinetics of pH changes at the surface of cancer cells in real time induced by the glucose infusion; - to establish the minimal size of metastatic and non-metastatic tumors, which can acidify microenvironment below pH 7.0.
描述(由申请人提供):酸度与各种病理状态的发展有关,如实体瘤、缺血性中风、神经创伤、癫痫发作、炎症、感染、伤口、囊性纤维化等。通过跨膜pH梯度和质膜表面pH值可将正常细胞与高度糖酵解的细胞(如转移性癌细胞)区分开来。我们建议开发一种新的工具来绘制体内细胞高度异质环境中单个细胞的细胞外和细胞内表面的pH值。该工具将为了解疾病进展和开发基于ph的图像引导干预方法提供机会。我们将采用光谱学和成像方法,从而实现细胞分辨率。我们的策略是基于pHLIP (pH低插入肽)家族的肽的使用。philips是水溶性膜肽,仅在微酸性条件下插入并折叠在膜的脂质双分子层中。由于在低pH下平衡强烈地向膜插入形式转移,因此pHLIP注入血液,在体内循环,并在肿瘤、炎性关节炎部位和缺血区域的酸性组织中积累。在口服或静脉注射pHLIP 24小时后,它被完全从血液中冲洗出来,停留在细胞外ph值较低的细胞的质膜中。用光学、PET或SPECT探针标记的pHLIP被认为是第一个酸度标记物,目前正在开发用于临床应用。我们计划用ph敏感荧光团snif -1将不同pKa的phillip肽偶联到4.5 - 6.5的膜上。使用philips的主要目的是将光学探针传送和系留到质膜双分子层的外层或内层。选择SNARF-1,因为它显示了发射光谱随pH值的变化,解决了探针浓度的校准问题。探针将连接到philips的N-或C-端。在第一种情况下,snaff -1将停留在细胞外空间,被拴在细胞表面。另一方面,当snawf -1与肽插入端(c端)结合时,pHLIP会将snawf -1“翻转”穿过双分子层,使其暴露在细胞内空间,同时使其靠近膜的内小叶。因此,我们建议从质膜的内外小叶测量pH值,并确定跨膜的pH梯度。将在溶液、2D和3D细胞培养以及小鼠癌症模型上进行实验。我们的目标是:-在三维培养中绘制细胞分裂和迁移过程中癌细胞表面的pH值;-绘制植入小鼠体内的肿瘤中单个细胞表面的pH值;-实时监测葡萄糖输注诱导的癌细胞表面pH变化动力学;-确定转移性和非转移性肿瘤的最小尺寸,可以酸化pH 7.0以下的微环境。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Oleg A Andreev其他文献

Oleg A Andreev的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Oleg A Andreev', 18)}}的其他基金

Mapping pH at the surface of individual cell
绘制单个细胞表面的 pH 值
  • 批准号:
    8413926
  • 财政年份:
    2012
  • 资助金额:
    $ 22.33万
  • 项目类别:
pHLIP Nanotechnology Platform for Cancer Imaging and Therapy
用于癌症成像和治疗的 pHLIP 纳米技术平台
  • 批准号:
    7910974
  • 财政年份:
    2009
  • 资助金额:
    $ 22.33万
  • 项目类别:
pHLIP Nanotechnology Platform for Cancer Imaging and Therapy
用于癌症成像和治疗的 pHLIP 纳米技术平台
  • 批准号:
    8266880
  • 财政年份:
    2008
  • 资助金额:
    $ 22.33万
  • 项目类别:
pHLIP Nanotechnology Platform for Cancer Imaging and Therapy
用于癌症成像和治疗的 pHLIP 纳米技术平台
  • 批准号:
    7640915
  • 财政年份:
    2008
  • 资助金额:
    $ 22.33万
  • 项目类别:
pHLIP Nanotechnology Platform for Cancer Imaging and Therapy
用于癌症成像和治疗的 pHLIP 纳米技术平台
  • 批准号:
    8079618
  • 财政年份:
    2008
  • 资助金额:
    $ 22.33万
  • 项目类别:
New Technology for Selective Delivery of PNAs in Cancer Cells In Vitro and In Viv
体外和体内癌细胞中选择性递送 PNA 的新技术
  • 批准号:
    7290218
  • 财政年份:
    2007
  • 资助金额:
    $ 22.33万
  • 项目类别:
New Technology for Selective Delivery of PNAs in Cancer Cells In Vitro and In Viv
体外和体内癌细胞中选择性递送 PNA 的新技术
  • 批准号:
    7483276
  • 财政年份:
    2007
  • 资助金额:
    $ 22.33万
  • 项目类别:
Mechanism and Uses of Transmembrane Helix Insertion by Soluble Peptides
可溶性肽跨膜螺旋插入的机制和用途
  • 批准号:
    8106730
  • 财政年份:
    2006
  • 资助金额:
    $ 22.33万
  • 项目类别:
Mechanism and Uses of Transmembrane Helix Insertion by Soluble Peptides
可溶性肽跨膜螺旋插入的机制和用途
  • 批准号:
    8280406
  • 财政年份:
    2006
  • 资助金额:
    $ 22.33万
  • 项目类别:
Mechanism and Uses of Transmembrane Helix Insertion by Soluble Peptides
可溶性肽跨膜螺旋插入的机制和用途
  • 批准号:
    10343727
  • 财政年份:
    2006
  • 资助金额:
    $ 22.33万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 22.33万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 22.33万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 22.33万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 22.33万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 22.33万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 22.33万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 22.33万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 22.33万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 22.33万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 22.33万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了